![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
T Eschenhagen, U Mende, M Diederich, M Nose, W Schmitz, H Scholz, J Schulte am Esch, A Warnholtz and H Schafer
Abteilung Allgemeine Pharmakologie, Universitats-Krankenhaus Eppendorf, Hamburg, FRG.
Chronic stimulation of beta-adrenoceptors leads to increased mRNA and protein levels of pertussis toxin (PTX)-sensitive guanine nucleotide- binding proteins (G proteins) in the heart. In the present study the time course is reported of the effect of isoprenaline infusions on myocardial mRNA levels of Gi alpha-2, Gi alpha-3, G(o) alpha, Gs alpha, and G beta and myocardial levels of PTX-sensitive G proteins. Rats were treated by subcutaneous infusions, with osmotic minipumps, of 0.9% NaCl, isoprenaline (2.4 mg/kg/day), propranolol (9.9 mg/kg/day), or a combination thereof for 1, 2, 3, 4, or 8 days, and two groups were treated with NaCl or isoprenaline for 13 or 26 days. Additional groups of rats were treated with 0.24 or 0.07 mg/kg/day for 4 days to determine the dose dependency of the effects of isoprenaline. mRNA concentrations were determined by standardized slot blotting with 32P- labeled cDNA or cRNA probes. In isoprenaline-treated rats, mRNA levels of all members of the Gi alpha/G(o) alpha family increased gradually in parallel. The increase in Gi alpha-2, Gi alpha-3, and G(o) alpha mRNA levels reached significance on days 2-3, reached maximal values on days 3-4, and remained stable over the total time of treatment of up to 26 days. Compared with NaCl, maximal increases were 77% (Gi alpha-2; 16.4 versus 9.3 pg/micrograms), 58% (Gi alpha-3; 4.65 versus 2.95 pg/micrograms), and 78% (G(o) alpha; 0.40 versus 0.22 pg/microgram). Gs alpha mRNA levels (about 30 pg/micrograms) and G beta mRNA levels remained unchanged. In isoprenaline-treated rats myocardial levels of PTX-sensitive G proteins increased by maximally 54%, compared with control. The time course differed slightly from the time course of mRNA up-regulation in the first 3 days of treatment and paralleled the increase in mRNA levels from day 4 on. Propranolol had no effect on G alpha mRNA or protein levels when given alone but abolished all effects of isoprenaline when given in combination. Isoprenaline at a dose of 0.24 mg/kg/day still induced an increase in Gi alpha-2 mRNA levels of 24%, without any effects on histopathology of the myocardium.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M. A Movsesian Altered cAMP-mediated signalling and its role in the pathogenesis of dilated cardiomyopathy Cardiovasc Res, June 1, 2004; 62(3): 450 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. U Muller, P. Boknik, J. Knapp, B. Linck, H. Luss, J. Neumann, and W. Schmitz Activation and inactivation of cAMP-response element-mediated gene transcription in cardiac myocytes Cardiovasc Res, October 1, 2001; 52(1): 95 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-P. Xiao, H. Cheng, Y.-Y. Zhou, M. Kuschel, and E. G. Lakatta Recent Advances in Cardiac {beta}2-Adrenergic Signal Transduction Circ. Res., November 26, 1999; 85(11): 1092 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J. Owen, P. B. J. Burton, M. C. Michel, O. Zolk, M. Bohm, J. R. Pepper, P. J. R. Barton, M. H. Yacoub, and S. E. Harding Myocardial Dysfunction in Donor Hearts : A Possible Etiology Circulation, May 18, 1999; 99(19): 2565 - 2570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bohm, M. Castellano, M. Flesch, C. Maack, M. Moll, M. Paul, F. Schiffer, and O. Zolk Chamber-Specific Alterations of Norepinephrine Uptake Sites in Cardiac Hypertrophy Hypertension, November 1, 1998; 32(5): 831 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bohm, S. Ettelbruck, M. Flesch, W. H van Gilst, A. Knorr, C. Maack, Y. M Pinto, M. Paul, A. C.H Teisman, and O. Zolk {beta}-Adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy Cardiovasc Res, October 1, 1998; 40(1): 146 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Linck, P. Bokník, H. A. Baba, T. Eschenhagen, U. Haverkamp, E. Jäckel, L. R. Jones, U. Kirchhefer, J. Knapp, S. Läer, et al. Long-term Beta Adrenoceptor-Mediated Alteration in Contractility and Expression of Phospholamban and Sarcoplasmic Reticulum Ca++-ATPase in Mammalian Ventricle J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 531 - 538. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-L. Lécrivain, J. Cohen-Tannoudji, M.-T. Robin, N. Coudouel, C. Legrand, and J.-P. Maltier Molecular Mechanisms of Adenylyl Cyclase Desensitization in Pregnant Rat Myometrium following In Vivo Administration of the ss-Adrenergic Agonist, Isoproterenol Biol Reprod, July 1, 1998; 59(1): 45 - 52. [Abstract] [Full Text]
|
|
|
|
|
|
M. Bohm, O. Zolk, M. Flesch, F. Schiffer, P. Schnabel, J.-P. Stasch, and A. Knorr Effects of Angiotensin II Type 1 Receptor Blockade and Angiotensin-Converting Enzyme Inhibition on Cardiac ß-Adrenergic Signal Transduction Hypertension, March 1, 1998; 31(3): 747 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Engelhardt, W. Zieger, J. Kassubek, M. C. Michel, M. J. Lohse, and O.-E. Brodde Tocolytic Therapy with Fenoterol Induces Selective Down-Regulation of {beta}-Adrenergic Receptors in Human Myometrium J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1235 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Eschenhagen, U. Mende, M. Diederich, B. Hertle, C. Memmesheimer, A. Pohl, W. Schmitz, H. Scholz, M. Steinfath, M. Bohm, et al. Chronic Treatment With Carbachol Sensitizes the Myocardium to cAMP-Induced Arrhythmia Circulation, February 15, 1996; 93(4): 763 - 771. [Abstract] [Full Text]
|
|
|
|
|
|
M. Bohm, M. Castellano, E. Agabiti-Rosei, M. Flesch, M. Paul, and E. Erdmann Dose-Dependent Dissociation of ACE-Inhibitor Effects on Blood Pressure, Cardiac Hypertrophy, and ß-Adrenergic Signal Transduction Circulation, November 15, 1995; 92(10): 3006 - 3013. [Abstract] [Full Text]
|
|
|
|
|
|
F. U. Muller, P. Boknik, A. Horst, J. Knapp, B. Linck, W. Schmitz, U. Vahlensieck, M. Bohm, M. C. Deng, and H. H. Scheld cAMP Response Element Binding Protein Is Expressed and Phosphorylated in the Human Heart Circulation, October 15, 1995; 92(8): 2041 - 2043. [Abstract] [Full Text]
|
|
|
|
 |
|
 S.-J. Zhang, H. Cheng, Y.-Y. Zhou, D.-J. Wang, W. Zhu, B. Ziman, H. Spurgoen, R. J. Lefkowitz, E. G. Lakatta, W. J. Koch, et al. Inhibition of Spontaneous beta 2-Adrenergic Activation Rescues beta 1-Adrenergic Contractile Response in Cardiomyocytes Overexpressing beta 2-Adrenoceptor J. Biol. Chem., July 7, 2000; 275(28): 21773 - 21779. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
